Stay updated with breaking news from Kare Schultz. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Teva Pharmaceutical Industries expects to finalise an opioid settlement in the United States by year-end and start paying in 2023, its chief executive said on Sunday, while also questioning the company's very low share price.
$4.35 billion settlement - set to span over 23 years - follows years-long litigation of lawsuits against pharma giant for their role in playing down risks of addiction, fueling the opioid pandemic
By Steven Scheer
Pharmaceutical company Teva has agreed in principle to pay $4.25 billion after reaching a nationwide settlement with multiple states and ...
Proposal calls pharmaceutical company to pay state and local governments up to $3.7 billion in cash over 13 years plus a contribution of $1.2 billion worth of opioid overdose reversal drug